1. Home
  2. PRPO vs OMH Comparison

PRPO vs OMH Comparison

Compare PRPO & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • OMH
  • Stock Information
  • Founded
  • PRPO N/A
  • OMH 2015
  • Country
  • PRPO United States
  • OMH Singapore
  • Employees
  • PRPO N/A
  • OMH N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • OMH Real Estate
  • Sector
  • PRPO Industrials
  • OMH Finance
  • Exchange
  • PRPO Nasdaq
  • OMH Nasdaq
  • Market Cap
  • PRPO 9.9M
  • OMH 8.4M
  • IPO Year
  • PRPO N/A
  • OMH 2023
  • Fundamental
  • Price
  • PRPO $8.31
  • OMH $0.35
  • Analyst Decision
  • PRPO
  • OMH Strong Buy
  • Analyst Count
  • PRPO 0
  • OMH 1
  • Target Price
  • PRPO N/A
  • OMH $1.50
  • AVG Volume (30 Days)
  • PRPO 5.2K
  • OMH 147.3K
  • Earning Date
  • PRPO 03-28-2025
  • OMH 09-25-2024
  • Dividend Yield
  • PRPO N/A
  • OMH N/A
  • EPS Growth
  • PRPO N/A
  • OMH N/A
  • EPS
  • PRPO N/A
  • OMH N/A
  • Revenue
  • PRPO $17,411,000.00
  • OMH $5,390,607.00
  • Revenue This Year
  • PRPO $75.18
  • OMH $101.90
  • Revenue Next Year
  • PRPO N/A
  • OMH $38.34
  • P/E Ratio
  • PRPO N/A
  • OMH N/A
  • Revenue Growth
  • PRPO 31.31
  • OMH 25.77
  • 52 Week Low
  • PRPO $4.31
  • OMH $0.32
  • 52 Week High
  • PRPO $8.75
  • OMH $1.15
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 75.47
  • OMH 46.15
  • Support Level
  • PRPO $7.02
  • OMH $0.33
  • Resistance Level
  • PRPO $7.54
  • OMH $0.45
  • Average True Range (ATR)
  • PRPO 0.34
  • OMH 0.03
  • MACD
  • PRPO 0.09
  • OMH 0.00
  • Stochastic Oscillator
  • PRPO 80.52
  • OMH 17.24

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.

Share on Social Networks: